Endpoint Clinical

Pharmaceutical ManufacturingNorth Carolina, United States501-1000 Employees

Endpoint Clinical provides RTSM and related services for clinical trials through its Elosity platform, offering continuous and flexible support throughout a study. Drawing on decades of experience, the company emphasizes proactive problem-solving to anticipate and resolve issues before they escalate and to incorporate changes smoothly into trial operations. The firm positions itself as an extension of sponsors' teams, aiming to minimize friction and risk so clinical staff can focus on trial success.

Headquartered in Raleigh, North Carolina, the company operates with offices across the US, Europe, and Asia and serves pharmaceutical sponsors and trial teams seeking RTSM capabilities. In April 2026, Endpoint released Elosity R3, a major update to its RTSM platform, expanding its capabilities for clinical supply and trial insights. In December 2025, it was recognized as a Leader in the Everest Group Life Sciences RTSM PEAK Matrix assessment.

Sign up for free to view info

Email Format Employee directory